Marinomed Biotech AG Secures Licensing Agreement for Carragelose® Distribution in Europe

Marinomed Biotech AG has finalized a licensing agreement with a prominent Consumer Health Care company for the distribution of its Carragelose® products in Europe. This partnership, an extension with an existing partner, encompasses several EU and non-EU countries, subject to regulatory approvals. Under the agreement, Marinomed is poised to receive milestone payments based on regulatory and commercial successes.

"This collaboration marks a significant advancement and recognition of our Carragelose product line," said Andreas Grassauer, CEO of Marinomed. "Entering additional markets is a crucial step, and we are eager to explore the full potential of our products."